Planning a sale, move, or exit before 2028? Book a 20-minute intro call →
Holding QSBS? Get a fixed-fee Section 1202 issue-spotting review →
Planning for Washington’s 9.9% income tax, effective January 1, 2028? Get the Tax Planning Guide →

Startup Financing

Summary

Overview of startup financing topics: SAFEs, convertible notes, priced equity rounds, term sheets, and securities law for founders and early-stage companies.

Introduction

Financing a startup often involves more than just selling shares. Founders frequently use SAFEs (simple agreements for future equity) and convertible promissory notes before a priced equity round, sometimes together with warrants that provide rights to purchase shares. Each instrument has distinct terms, valuation mechanics, and tax consequences.

Key topics covered on the blog

  • Convertible notes vs. SAFEs — We compare convertible promissory notes and SAFEs, explaining when each might be appropriate and highlighting the risks of accumulating multiple instruments without a clear capitalization plan.
  • Warrants: the tax story — Warrants provide rights to purchase shares on specified terms. For a purchased, noncompensatory stock warrant, ordinary cash exercise generally does not itself trigger gain; the warrant’s cost and exercise payment generally become stock basis. Sale, expiration, and cashless settlement require separate analysis. Compensatory warrants can produce ordinary income under Section 83. Warrants issued with debt can create original issue discount and taxable interest before exercise. See IRS Publication 550, the compensatory-option rules, and the debt-and-warrant allocation rules.
  • Redemptions and QSBS — Certain redemptions can disqualify QSBS treatment. Before repurchasing founder shares or redeeming investors, ensure you understand the Section 1202 rules.
  • Preferred stock and venture capital — We outline typical preferred stock terms such as liquidation preferences, pro rata rights and protective provisions, and discuss negotiating term sheets with venture capital investors.

Navigating early‑stage financings requires careful consideration of valuation, dilution and tax issues. We advise founders and investors on drafting SAFE and note documents, negotiating term sheets and structuring deals to align interests.

Ready to get started?

  • Schedule a consultation — Book a time on our calendar to discuss your fundraising strategy.
  • Contact us — Reach us through our contact page with your questions.
  • Subscribe for updates — Join our newsletter to receive insights on startup financings, SAFEs, notes and warrants.
Share on Facebook Share on Linkedin Share on Twitter Send by email

Subscribe to the newsletter

Subscribe to the newsletter for the latest news and work updates straight to your inbox, every week.

Subscribe